TTrialPathMatch Me to Trials
← Back to trials
RecruitingUlcerative Colitis (UC)

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Eligible age

18–75 yrs

Accepts

All genders

Locations

11 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XmAb942 in healthy volunteers (Parts A and B). Part C of this study will be a Phase 2 study to evaluate XmAb942 in participants with ulcerative colitis (UC).

Sponsor: Xencor, Inc.

You may qualify if…

  • ✓ Parts A and B
  • ✓ Age 18-55
  • ✓ Must be in good health with no significant medical history
  • ✓ Clinical laboratory values within normal range
  • ✓ BMI 18-35 (inclusive)
  • ✓ Contraceptive use by men or women consistent with local regulations
  • ✓ Able and willing to provide written informed consent
  • ✓ Part C

You may not qualify if…

  • ✕ Parts A and B
  • ✕ Any physical or psychological condition that prohibits study completion
  • ✕ History of suicidal behavior or suicidal ideation
  • ✕ Heavy use of nicotine containing products
  • ✕ HIV, hepatitis B and hepatitis C positive
  • ✕ Cardiac arrhythmia, or clinically significant abnormal ECG
  • ✕ Active use of prescription medications within 14 days of Day -1
  • ✕ Active use of over-the-counter, or herbal medication within 7 days of Screening

Where it's recruiting

Arizona

Scottsdale

California

Palo Alto

Florida

Bradenton · Brandon · Jacksonville · Kissimmee …

Kentucky

Louisville

Mississippi

Oxford · Tupelo

New York

Albany · Rochester

Ohio

Beavercreek

Tennessee

Cordova

Texas

Cedar Park · Denton · Garland · Georgetown …

Virginia

Richmond

Source: ClinicalTrials.gov · NCT06619990 · last updated 2026-10-30

Study of XmAb942 in Healthy Participants and Participants With Ulcerat · TrialPath